Non-monotonic dose-response effects of arsenic on glucose metabolism

• Published in: Toxicology and applied pharmacology 2019-08, Vol.377, p.114605-114605, Article 114605
• Main Authors: Gong, Yingyun, Liu, Jidong, Xue, Yanfeng, Zhuang, Zhong, Qian, Sichong, Zhou, Wenjun, Li, Xin, Qian, Justin, Ding, Guolian, Sun, Zheng
• Format: Article
• Language: English
• Subjects: Amino Acids - metabolism; Animals; Arsenic; Arsenic - toxicity; Dose Effect; Dose-Response Relationship, Drug; Fatty Acids - metabolism; Glucose - metabolism; Glucose Clamp Technique; Glucose Intolerance; Insulin Resistance; Insulin Sensitivity; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal - drug effects; Muscle, Skeletal - metabolism; Pancreas - drug effects; Pancreas - metabolism; Poisons - toxicity; Pyruvic Acid - metabolism
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1016/j.taap.2019.114605

Inorganic arsenic (iAs) is a widespread environmental toxin. In addition to being a human carcinogen, its effect on diabetes has started to gain recognition recently. Insulin is the key hormone regulating systemic glucose metabolism. The in vivo effect of iAs on insulin sensitivity has not been directly addressed. Here we use mouse models to dissect the dose-dependent effects of iAs on glucose metabolism in vivo. We performed hyperinsulinemic-euglycemic clamp, the gold standard analysis of systemic insulin sensitivity. We also performed dynamic metabolic testings and RNA-seq analysis. We found that a low-dose exposure (0.25 ppm iAs in drinking water) caused glucose intolerance in adult male C57BL/6 mice, likely by disrupting glucose-induced insulin secretion without affecting peripheral insulin sensitivity. However, a higher-dose exposure (2.5 ppm iAs) had diminished effects on glucose tolerance despite disrupted pancreatic insulin secretion. Insulin Clamp analysis showed that 2.5 ppm iAs actually enhanced systemic insulin sensitivity by simultaneously enhancing insulin-stimulated glucose uptake in skeletal muscles and improved insulin-mediated suppression of endogenous glucose production. RNA-seq analysis of skeletal muscles revealed that 2.5 ppm iAs regulated expression of many genes involved in the metabolism of fatty acids, pyruvate, and amino acids. These findings suggest that iAs has opposite glycemic effects on distinct metabolic tissues at different dose thresholds. Such non-monotonic dose-response effects of iAs on glucose tolerance shed light on the complex interactions between iAs and the systemic glucose metabolism, which could potentially help reconcile some of the conflicting results in human epidemiological studies. •The first insulin clamp analysis in arsenic toxicity•Tissue-specific effects of arsenic in glucose metabolism•Non-monotonic dose response effects of arsenic in glucose tolerance•Arsenic non-canonically affects muscle glucose metabolism